[3H]PSB-22219

N/A

Report date: 2025/10/20 14:18:46

NME

Base Information

Drug Name[3H]PSB-22219

Drug Alias NameN/A

ClassificationRadiation-emitting products > Nuclides > Hydrogen > 3HRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates

Mechanisms of ActionPurinergic receptor P2Y12 antagonists

TargetsPurinergic receptor P2Y12

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermanyFrance

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesUniversity Of Bonn Université Paris-Saclay

China Registration ClassN/A

Develop Information

Active CompaniesUniversité Paris-Saclay University Of Bonn

Inactive CompaniesN/A

Active IndicationsN/A

Inactive IndicationsN/A

Other Information

ATC CodeN/A